Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Sharon Gardner"'
Autor:
Girish Dhall, Ira J. Dunkel, Mohammad H Abu-Arja, Jason Fangusaro, Tom B. Davidson, Sharon Gardner, Jonathan L. Finlay, Joseph Stanek, Mohamed S. AbdelBaki
Publikováno v:
Pediatr Blood Cancer
Background We report the outcomes of patients with pineoblastoma and trilateral retinoblastoma syndrome enrolled on the Head Start (HS) I-III trials. Methods Twenty-three children were enrolled prospectively between 1991 and 2009. Treatment included
Autor:
Eveline Teresa Hidalgo, Peter Wu, Svetlana Kvint, Matija Snuderl, Jonathan Serrano, Sharon Gardner, Matthias A. Karajannis, Cordelia Orillac
Publikováno v:
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery. 36(1)
Molecular subgroups of pediatric brain tumors associated with divergent biological, clinical, and prognostic features have been identified. However, data regarding the impact of subgroup affiliation on the outcome of children with malignant brain tum
Autor:
Sarah Milla, Matthew Winfeld, Els Fieremans, Matthias A. Karajannis, Joseph A. Helpern, Jens H. Jensen, Vitria Adisetiyo, Jeffrey C. Allen, Sharon Gardner
Publikováno v:
Journal of Pediatric Neuroradiology. :301-305
The purpose of this study is to determine the accuracy with which a non-Gaussian measure of diffusion, mean kurtosis (MK), predicts the histologic grade of pediatric brain tumors. After institutional review board approval, 21 World Health Organizatio
Autor:
Sharon Gardner, Jeffrey C. Allen, Andrea Cappellano, Clara Belessiotis, Nicholas G. Gottardo, Nasjla S. DaSilva, Mark Weinblatt, Jonathan L. Finlay, Girish Dhall, Blanca Diez, Rachel Pruitt
Publikováno v:
Pediatric Blood & Cancer. 62:1920-1924
Objectives To evaluate patterns of relapse and outcome in patients newly diagnosed with CNS Mixed Malignant GCT (MMGCT) treated initially with chemotherapy alone. Methods A retrospective chart review was conducted using all 25 patients enrolled on th
Publikováno v:
Pediatric Blood & Cancer. 62:1403-1408
Background Approximately one in 285 children will be diagnosed with cancer before reaching their 20th birthday. While both oncologists and parents report a preference that these children die at home rather than in a hospital, there are limited data e
Autor:
Vedat O. Yildiz, Maxim Yankelevich, Girish Dhall, Soumen Khatua, Sharon Gardner, Jonathan L. Finlay, Kevin Ginn, Robert J. Brown, Wafik Zaky
Publikováno v:
Pediatric Blood & Cancer. 62:784-789
Background Choroid plexus carcinoma (CPC) is a rare aggressive intracranial neoplasm with a predilection for young children and a historically poor outcome. Currently, no defined optimal therapeutic strategy exists. The Head Start (HS) regimens have
Autor:
Wendy B. London, Alan S. Gamis, Tanya M. Trippett, Shirley Hogan, Sharon Gardner, Lu Chen, R. Paul Guillerman, Pedro A. de Alarcon, Cindy L. Schwartz
Publikováno v:
Pediatric Blood & Cancer. 62:60-64
Background We assessed the safety and efficacy of ifosfamide and vinorelbine (IV) as a less toxic and effective reinduction regimen for pediatric patients with relapsed or refractory Hodgkin Lymphoma. Procedure This multi-center Children's Oncology G
Autor:
Kelly Ann Cervone, Jonathan L. Finlay, Sharon Gardner, Rakesh K. Goyal, K. M. Steve Lo, Diana S Osorio, Ira J. Dunkel
Publikováno v:
Pediatric bloodcancer. 65(1)
BACKGROUND: The purpose of this study was to determine the feasibility and tolerability of tandem courses of high-dose thiotepa with autologous hematopoietic cell rescue (AHCR) in patients with recurrent, refractory solid tumors who were ineligible f
Autor:
Stephen A. Sands, Christina G. Salley, Juliette Hukin, Judith D. Goldberg, Sharon Gardner, Aniket Saha, Jonathan L. Finlay, Suzanne Scott, Randal Olshefski, Linda Rolnitzky, Preeti Saigal
Publikováno v:
Pediatric Blood & Cancer. 61:1644-1672
Background Due to the devastating late effects associated with cranial irradiation in young children with central nervous system (CNS) tumors, treatment for these patients has evolved to include the use of intensive chemotherapy to either avoid or po
Autor:
Sharon Gardner, Anat Erdreich-Epstein, Reuben Antony, Moneil Patel, Girish Dhall, Jonathan L. Finlay, Gordon McComb, Mark D. Krieger, Kenneth E. Wong, Floyd H. Gilles, Arthur J. Olch, Richard Sposto
Publikováno v:
Pediatric Blood & Cancer. 61:1195-1201
Background Recurrence occurs in almost 50% of patients with intracranial ependymoma, and their outcome following recurrence is poor. Methods We retrospectively reviewed the medical records of 22 patients with intracranial ependymoma and subsequent re